Apixaban dose for an 84-year-old woman
PEBC OSCE practice station

Drug information · 2 min to read · 7 min to perform

Open this station

A written station. Free to try, no sign-up.

The task

You are a pharmacist in a community pharmacy. You have received a written drug-information request from a physician, Dr Marcus Ellery, in the patient folder. Use the information provided and the references you know. Write a short, clear reply to the physician in the response sheet, giving your recommendation, the reasons for it and the monitoring you suggest. If information is missing, say what you need. The assessor will not take part.

Answer for this station

What a strong answer does

  • Replies in a professional letter format addressed to the physician, with a clear recommendation in the first lines.
  • Safety: Recommends apixaban 2.5 mg twice daily, not 5 mg twice daily.
  • States the dose-reduction criteria: at least two of age 80 or older, weight 60 kg or less, creatinine 133 micromol/L or higher.
  • Applies the criteria correctly to the patient: age and weight met, creatinine not met.
  • Calculates or interprets the creatinine clearance correctly (about 33 mL/min) and comments on its relevance.
  • Checks for other relevant factors: bleeding history, concurrent antiplatelets or NSAIDs, interacting medicines and liver function, and asks for missing information.
  • Suggests monitoring: kidney function, hemoglobin and liver tests, reassessing the dose with changes, adherence and bleeding counselling.
  • Cites or refers to the product monograph or a recognized Canadian resource and invites further contact.

Model answer

I write a short, professional reply to Dr Ellery and state my recommendation at the start: apixaban 2.5 mg twice daily rather than 5 mg twice daily. I give the reasons. In non-valvular atrial fibrillation, apixaban is reduced from 5 mg to 2.5 mg twice daily when a patient meets at least two of three criteria: age 80 years or older, body weight 60 kg or less, and serum creatinine 133 micromol/L or higher. This patient is 84 years old and weighs 57 kg, so she meets two criteria. Her creatinine of 100 micromol/L does not meet the third, so the reduction depends on age and weight. I also estimate her creatinine clearance using Cockcroft-Gault: (140 - 84) x 57 x 1.04 / 100, which is about 33 mL/min: above 30 mL/min but still reduced, so it needs watching. I note that amlodipine has no significant interaction. I ask for the information I need to be confident: her recent hemoglobin and liver tests, and confirmation that she takes no NSAIDs. Under the Canadian Cardiovascular Society algorithm her age alone supports anticoagulation, so the question is the dose, not the indication. For monitoring I suggest checking kidney function and hemoglobin before starting and at least yearly, sooner if she becomes ill or her weight or kidney function changes, and revisiting the dose criteria at each review. I advise counselling on twice-daily adherence, signs of bleeding and avoiding NSAIDs and aspirin unless prescribed. I suggest he confirm the dose in the current monograph and invite him to call me to discuss.

What this station tests

  • Lead with the answer in a drug-information reply.
  • Apply dose-reduction criteria one by one and show which are met.
  • Show the creatinine clearance working.
  • State what information is missing.
  • Suggest monitoring and counselling.

Sources for the clinical content

An original practice scenario with invented patients. Not an exam question. Written from the guidance above and reviewed before release: how we write and check stations.

Practise next

About the PEBC OSCE →